Innoviva (INVA) FCF Payout Ratio (QoQ) (2014 - 2022)
Innoviva (INVA) FCF Payout Ratio (QoQ) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 199.72% |
| Jun 30, 2022 | 82.13% |
| Sep 30, 2021 | -26.70% |
| Jun 30, 2021 | -5.85% |
| Mar 31, 2021 | 759.15% |
| Jun 30, 2020 | -29.23% |
| Mar 31, 2020 | 236.55% |
| Dec 31, 2019 | -185.81% |
| Sep 30, 2019 | 94,223.74% |
| Dec 31, 2018 | 50.05% |
| Sep 30, 2018 | 111.55% |
| Jun 30, 2018 | 767.42% |
| Mar 31, 2018 | -36.08% |
| Dec 31, 2017 | -15.98% |
| Sep 30, 2017 | 213.43% |
| Jun 30, 2017 | -222.62% |
| Mar 31, 2017 | -21.81% |
| Dec 31, 2016 | 18.40% |
| Sep 30, 2016 | -73.82% |
| Jun 30, 2016 | -89.96% |